ENDONOVO THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2023.
  • Endonovo Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$473K, a 4.83% increase year-over-year.
  • Endonovo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$2.62M, a 17.1% increase year-over-year.
  • Endonovo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$3.26M, a 46.6% decline from 2021.
  • Endonovo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$2.23M, a 23.5% increase from 2020.
  • Endonovo Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$2.91M, a 23.5% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.62M -$473K +$24K +4.83% Jul 1, 2023 Sep 30, 2023 10-Q/A 2023-12-29
Q2 2023 -$2.64M -$1.13M +$667K +37.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$3.31M -$529K -$43.5K -8.96% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$3.26M -$483K -$109K -29.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 -$3.16M -$497K +$195K +28.2% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-12-29
Q2 2022 -$3.35M -$1.8M -$1.23M -216% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$2.12M -$486K +$105K +17.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$2.23M -$374K +$310K +45.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$2.54M -$692K +$255K +26.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$2.79M -$570K +$31.8K +5.28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$2.82M -$590K +$89.2K +13.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q4 2020 -$2.91M -$684K +$46K +6.31% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-14
Q3 2020 -$2.96M -$947K +$344K +26.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$3.3M -$602K +$373K +38.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$3.68M -$680K +$133K +16.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$3.81M -$730K +$302K +29.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-13
Q3 2019 -$4.11M -$1.29M -$256K -24.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-19
Q2 2019 -$3.86M -$975K -$158K -19.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$3.7M -$813K +$462K +36.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-12
Q4 2018 -$4.16M -$1.03M -$199K -23.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-04
Q3 2018 -$3.96M -$1.04M +$412 +0.04% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$3.96M -$817K +$1.36M +62.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.32M -$1.28M -$718K -129% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$4.6M -$833K -$200K -31.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-15
Q3 2017 -$4.4M -$1.04M +$275K +21% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$4.68M -$2.18M -$113K -5.45% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$4.57M -$558K +$845K +60.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-18
Q4 2016 -$5.41M -$633K +$537K +45.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-06
Q3 2016 -$5.95M -$1.31M -$841K -179% Jul 1, 2016 Sep 30, 2016 10-Q/A 2017-11-09
Q2 2016 -$5.11M -$2.07M -$1.57M -318% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$3.54M -$1.4M -$970K -225% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$2.56M -$1.17M -$999K -586% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$1.57M -$470K +$157K +25.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.72M -$494K +$333K +40.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$2.06M -$432K +$135K +23.9% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-05-27
Q4 2014 -$2.19M -$171K +$323K +65.5% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-05-17
Q3 2014 -$2.51M -$627K -$199K -46.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$2.32M -$826K -$345K -71.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$1.97M -$567K +$458K +44.7% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-15
Q4 2013 -$2.43M -$494K +$54.5K +9.94% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-06-15
Q3 2013 -$2.48M -$428K -$55.2K -14.8% Jul 1, 2013 Sep 30, 2013 10-Q 2013-12-18
Q2 2013 -$2.43M -$482K -$85.9K -21.7% Apr 1, 2013 Jun 30, 2013 10-Q/A 2013-08-28
Q1 2013 -$2.34M -$1.03M -$600K -141% Jan 1, 2013 Mar 31, 2013 10-Q/A 2013-06-21
Q4 2012 -$1.74M -$549K -$43.9K -8.7% Oct 1, 2012 Dec 31, 2012 10-K/A 2013-05-03
Q3 2012 -$1.7M -$373K Jul 1, 2012 Sep 30, 2012 10-Q 2013-12-18
Q2 2012 -$396K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-28
Q1 2012 -$426K -$426K Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-06-21
Q4 2011 -$505K Sep 1, 2011 Dec 31, 2011 10-K/A 2013-05-03
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.